| Community Health Centers Del Valle | |
|
430 S Blosser Rd Santa Maria CA 93458-4908 | |
| (805) 361-8900 | |
| (805) 361-8990 |
| Full Name | Community Health Centers Del Valle |
|---|---|
| Speciality | Clinic/Center |
| Location | 430 S Blosser Rd, Santa Maria, California |
| Authorized Official Name and Position | Ronald E Castle (CHIEF EXECUTIVE OFFICER) |
| Authorized Official Contact | 8053618014 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Community Health Centers Del Valle 2050 S Blosser Rd Santa Maria CA 93458-7310 Ph: (805) 361-8028 | Community Health Centers Del Valle 430 S Blosser Rd Santa Maria CA 93458-4908 Ph: (805) 361-8900 |
| NPI Number | 1174911317 |
|---|---|
| Provider Enumeration Date | 12/22/2014 |
| Last Update Date | 01/21/2019 |
| Medicare PECOS PAC ID | 7416868120 |
|---|---|
| Medicare Enrollment ID | O20150902001289 |
News Archive
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.
Carlos Moreira, Chairman and Founder of WISeKey, is to unveil his vision and plans towards the region in an address to a selected audience of over 500 entrepreneurs and members of the science community in New England during the traditional MIT Latin Conference to be held this week-end in Cambridge, Massachusetts.
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that overactivation of the RANK signalling pathway promotes the initiation, progression and metastasis of tumours in human breast epithelial cells by dedifferentiation of breast cells to stem cells. The results of this study have been advanced in the electronic edition of the journal Cancer Research.
Breast cancer patients are more likely to have joint pain from taking aromatase inhibitors if they have advanced stage cancer, according to a study presented at the American College of Rheumatology's annual meeting, held Nov. 7-11, in Atlanta. The study is one of the first to identify factors that increase the likelihood that a patient will suffer joint pain from AI therapy.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174911317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
News Archive
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.
Carlos Moreira, Chairman and Founder of WISeKey, is to unveil his vision and plans towards the region in an address to a selected audience of over 500 entrepreneurs and members of the science community in New England during the traditional MIT Latin Conference to be held this week-end in Cambridge, Massachusetts.
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that overactivation of the RANK signalling pathway promotes the initiation, progression and metastasis of tumours in human breast epithelial cells by dedifferentiation of breast cells to stem cells. The results of this study have been advanced in the electronic edition of the journal Cancer Research.
Breast cancer patients are more likely to have joint pain from taking aromatase inhibitors if they have advanced stage cancer, according to a study presented at the American College of Rheumatology's annual meeting, held Nov. 7-11, in Atlanta. The study is one of the first to identify factors that increase the likelihood that a patient will suffer joint pain from AI therapy.
› Verified 5 days ago
Santa Barbara County Public Health Department-good Samaritan Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 401 W Morrison Ave, Santa Maria, CA 93458 Phone: 805-347-3338 | |
Med Plus Central Coast Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2271 S Depot St, Santa Maria, CA 93455 Phone: 805-922-0561 Fax: 805-922-0083 | |
Santa Barbara County Public Health Dept-santa Maria Health Care Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2115 Centerpointe Pkwy, Santa Maria, CA 93455 Phone: 805-346-7230 Fax: 805-346-8449 | |
Robert S. Barry Md, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1420 S Miller St Ste A, Santa Maria, CA 93454 Phone: 805-922-3033 | |
Restorative Spine & Joint Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3596 Skyway Dr Ste B, Santa Maria, CA 93455 Phone: 805-614-7820 | |
Nightingale Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1414 S Miller St, Suite 4, Santa Maria, CA 93454 Phone: 805-349-6336 | |
Marian Community Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1745 N Broadway Ste 101, Santa Maria, CA 93454 Phone: 805-739-3890 Fax: 805-347-7697 |